Drug Safety Update
admin December 4th, 2007
The MHRA’s Drug Safety Update is out: Volume 1, Issue 5, December 2007 [PDF here]
This month:
Recombinant human erythropoietins: new prescribing advice
Rosiglitazone and pioglitazone: cardiovascular safety
Dosulepin: measures to reduce risk of fatal overdose
ACE inhibitors and angiotensin II receptor antagonists: not for use in pregnancy
Short-acting β agonists: myocardial ischaemia
Yellow Card scheme update: electronic reporting
Varenicline: possible effects on driving, and psychiatric illness
NSAIDs and coxibs: balancing of cardiovascular and gastrointestinal risks
Aprotinin: suspension of Marketing Authorisations
Lumiracoxib: suspension of Marketing Authorisations
Strontium ranelate: risk of severe allergic reactions
Talc for pleurodesis: risk of adverse events
Recent letters to healthcare professionals
Other information from the MHRA
New sections on the MHRA website